Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028
Triton’s report intimates that
the Latin American stem cell market is probable to showcase growth at a CAGR of
6.18% during the assessed period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this
market include:
• Brazil
• Mexico
• Rest of Latin America
In Brazil, among the urology
diseases, prostate cancer, overactive bladder, renal diseases, and urinary
tract infections are significant conditions that are highly prevalent. Due to
the low availability and elevated cost of procedures, hospitals usually have
long waiting lists for kidney transplants. Furthermore, several publications
relating to regenerative medicines and stem cell research in treating numerous
diseases, including brain cancer and diabetes, have gained significant
traction. Moreover, several research centers in the country are supporting stem
cell biology. These factors indicate a steady rise of the stem cell market
during the estimated years across Brazil.
On the other hand, the
government is known to invest mainly in improving Mexico’s healthcare
infrastructure. Although, the country has variant healthcare systems such as
public, private, and social security schemes, which further leads to multiple
inconsistencies in health coverage and related policies. Nevertheless, Mexico
is considered one of the popular medical tourism destinations, with tourists
seeking affordable and effective treatments. This is one of the major factors
expected to influence the demand for stem cell therapies.
Further, the Global Institute
of Stem Cell Therapy and Research is among the leading stem cell research
companies worldwide, offering stem cell therapy for anti-aging diseases,
several sclerosis, and other injuries. Hence, such developments in the
healthcare facilities are likely to propel the stem cell market on a positive
growth path across Mexico.
StemCell Technologies is a
biotechnology company cultivating specialty cell culture, cell isolation
systems, and accessory products for life science research activities. It
develops its products to assist the overall experimental workflows, including
expansion, maintenance, differentiation, and storage, among others. The company
has extended its product portfolio to include a detailed suite of immune cell
isolation devices, and products supporting research by utilizing pluripotent
and mesenchymal stem cells. It serves its broad client base in several regions,
such as North America and Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA STEM CELL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON STEM CELL MARKET
2.3. KEY
IMPACT ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.5. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AWARENESS ABOUT UMBILICAL CORD STEM CELLS
2.9.2. SURGE
IN STEM CELL RESEARCH AND DEVELOPMENT
2.9.3. RISING
DEMAND FOR REGENERATIVE MEDICINE
2.10. MARKET RESTRAINTS
2.10.1. ETHICAL CONCERNS ASSOCIATED
WITH STEM CELLS
2.10.2. HIGH COST OF STEM CELL
PROCEDURES
2.10.3. STRINGENT REGULATIONS IN TERMS
OF STEM CELL THERAPY
2.11. MARKET OPPORTUNITIES
2.11.1. ADVANCEMENT IN TECHNOLOGY
2.11.2. RISK OF ADVERSE IMMUNE
REACTIONS AND COMPLICATIONS
3. LATIN
AMERICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION
3.1. NEUROLOGICAL
DISORDERS
3.2. ONCOLOGY
DISORDERS
3.3. DIABETES
3.4. INJURIES
AND WOUNDS
3.5. ORTHOPEDIC
TREATMENTS
3.6. CARDIOVASCULAR
DISORDERS
3.7. OTHER
THERAPEUTIC APPLICATIONS
4. LATIN
AMERICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY
4.1. CRYOPRESERVATION
4.2. ACQUISITION
4.2.1. STEM
CELL APHERESIS
4.2.2. STEM
CELL BONE MARROW MARKET
4.2.3. STEM
CELL UMBILICAL CORD
4.3. EXPANSION
AND SUB-CULTURE
4.4. PRODUCTION
4.4.1. STEM
CELL CULTURE
4.4.2. THERAPEUTIC
CLONING
4.4.3. IVF
5. LATIN
AMERICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE
5.1. ALLOGENEIC
STEM CELL THERAPY
5.2. AUTOLOGIC
STEM CELL THERAPY
5.3. SYNGENEIC
STEM CELL THERAPY
6. LATIN
AMERICA STEM CELL MARKET OUTLOOK - BY PRODUCT
6.1. ADULT
STEM CELL
6.1.1. HEMATOPOIETIC
STEM CELL
6.1.2. NEURAL
STEM CELL
6.1.3. UMBILICAL
CORD STEM CELL
6.1.4. MESENCHYMAL
STEM CELL
6.1.5. DENTAL
STEM CELL
6.2. HUMAN
EMBRYONIC STEM CELL
6.3. PLURIPOTENT
6.4. MOUSE/RAT
NEURAL
7. LATIN
AMERICA STEM CELL MARKET OUTLOOK - BY APPLICATION
7.1. REGENERATIVE
MEDICINE
7.2. DRUG
DISCOVERY AND DEVELOPMENT
8. GEOGRAPHICAL
ANALYSIS - LATIN AMERICA
8.1. COUNTRY
ANALYSIS
8.1.1. MEXICO
8.1.2. BRAZIL
8.1.3. REST
OF LATIN AMERICA
9. COMPANY
PROFILES
9.1. CORNING
INC
9.2. STEMCELL
TECHNOLOGIES
9.3. STRYKER
CORPORATION
9.4. BECTON
DICKINSON AND COMPANY (BD)
9.5. CYTORI
THERAPEUTICS
9.6. QIAGEN
NV
9.7. GE
HEALTHCARE
9.8. TAKARA
HOLDINGS
9.9. SMITH
& NEPHEW PLC
9.10. INTERNATIONAL STEM CELL CORP
9.11. MILTENYI BIOTEC
9.12. MERCK KGAA (SIGMA ALDRICH)
9.13. THERMO FISHER SCIENTIFIC INC
9.14. ALLCELLS LLC
9.15. PLURISTEM THERAPEUTICS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE &
DELIVERABLES
10.1.1. OBJECTIVES OF STUDY
10.1.2. SCOPE OF STUDY
10.2. SOURCES OF DATA
10.2.1. PRIMARY DATA SOURCES
10.2.2. SECONDARY DATA SOURCES
10.3. RESEARCH METHODOLOGY
10.3.1. EVALUATION OF PROPOSED MARKET
10.3.2. IDENTIFICATION OF DATA SOURCES
10.3.3. ASSESSMENT OF MARKET
DETERMINANTS
10.3.4. DATA COLLECTION
10.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 LATIN AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION,
2021-2028 (IN $ MILLION)
TABLE 4 LATIN AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN
$ MILLION)
TABLE 5 LATIN AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 6 LATIN AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 7 LATIN AMERICA STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028
(IN $ MILLION)
TABLE 8 LATIN AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $
MILLION)
TABLE 9 LATIN AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN
$ MILLION)
TABLE 10 LATIN AMERICA STEM CELL MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 11 LATIN AMERICA STEM CELL MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1 LATIN AMERICA STEM CELL MARKET, 2021-2028,
(IN $ MILLION)
FIGURE 2 LATIN AMERICA STEM CELL MARKET, BY
NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 3 LATIN AMERICA STEM CELL MARKET, BY
ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 4 LATIN AMERICA STEM CELL MARKET, BY
DIABETES, 2021-2028 (IN $ MILLION)
FIGURE 5 LATIN AMERICA STEM CELL MARKET, BY
INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
FIGURE 6 LATIN AMERICA STEM CELL MARKET, BY
ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7 LATIN AMERICA STEM CELL MARKET, BY
CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 8 LATIN AMERICA STEM CELL MARKET, BY OTHER
THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 9 LATIN AMERICA STEM CELL MARKET, BY
CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
FIGURE 10 LATIN AMERICA STEM CELL MARKET, BY
ACQUISITION, 2021-2028 (IN $ MILLION)
FIGURE 11 LATIN AMERICA STEM CELL MARKET, BY STEM CELL
APHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 12 LATIN AMERICA STEM CELL MARKET, BY STEM CELL
BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
FIGURE 13 LATIN AMERICA STEM CELL MARKET, BY STEM CELL
UMBILICAL CORD, 2021-2028 (IN $ MILLION)
FIGURE 14 LATIN AMERICA STEM CELL MARKET, BY EXPANSION
AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 15 LATIN AMERICA STEM CELL MARKET, BY
PRODUCTION, 2021-2028 (IN $ MILLION)
FIGURE 16 LATIN AMERICA STEM CELL MARKET, BY STEM CELL
CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 17 LATIN AMERICA STEM CELL MARKET, BY
THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
FIGURE 18 LATIN AMERICA STEM CELL MARKET, BY IVF,
2021-2028 (IN $ MILLION)
FIGURE 19 LATIN AMERICA STEM CELL MARKET, BY ALLOGENEIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 20 LATIN AMERICA STEM CELL MARKET, BY AUTOLOGIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 21 LATIN AMERICA STEM CELL MARKET, BY SYNGENEIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 22 LATIN AMERICA STEM CELL MARKET, BY ADULT STEM
CELL, 2021-2028 (IN $ MILLION)
FIGURE 23 LATIN AMERICA STEM CELL MARKET, BY
HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 24 LATIN AMERICA STEM CELL MARKET, BY NEURAL
STEM, 2021-2028 (IN $ MILLION)
FIGURE 25 LATIN AMERICA STEM CELL MARKET, BY UMBILICAL
CORD STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 26 LATIN AMERICA STEM CELL MARKET, BY
MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 27 LATIN AMERICA STEM CELL MARKET, BY DENTAL
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 28 LATIN AMERICA STEM CELL MARKET, BY HUMAN
EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 29 LATIN AMERICA STEM CELL MARKET, BY
PLURIPOTENT, 2021-2028 (IN $ MILLION)
FIGURE 30 LATIN AMERICA STEM CELL MARKET, BY MOUSE/RAT
NEURAL, 2021-2028 (IN $ MILLION)
FIGURE 31 LATIN AMERICA STEM CELL MARKET, BY
REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32 LATIN AMERICA STEM CELL MARKET, BY DRUG
DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 33 MEXICO STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 34 BRAZIL STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 35 REST OF LATIN AMERICA STEM CELL MARKET
2021-2028 (IN $ MILLION)